A role for peripheral somatostatin receptors in counter-irritation-induced analgesia

Neuroscience

Volumn 120, Issue 2, 2003, Pages 499-508

  Carlton, S M ^a   Zhou, S ^a   Kraemer, B ^a   Coggeshall, R E ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Complete Freund's adjuvant; Cyclo somatostatin; Diffuse noxious inhibitory controls; DNIC; Endogenous analgesia; Non opioid

Indexed keywords

ANTIBODY; ANTIPRURITIC AGENT; CAPSAICIN; CYCLO SOMATOSTATIN; FORMALDEHYDE; FREUND ADJUVANT; HORMONE RECEPTOR BLOCKING AGENT; NALOXONE; OCTREOTIDE; OPIATE RECEPTOR; PEPTIDE; SOMATOSTATIN; SOMATOSTATIN RECEPTOR; SOMATOSTATIN RECEPTOR ANTAGONIST; UNCLASSIFIED DRUG; CYCLOPEPTIDE; CYCLOSOMATOSTATIN;

ANALGESIA; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BEHAVIOR; CONTROLLED STUDY; DRUG ACTIVATION; DRUG EFFECT; DRUG SPECIFICITY; ENZYME ACTIVATION; HINDLIMB; HYPOTHESIS; INJECTION; MALE; NERVE FIBER; NOCICEPTION; NOCICEPTIVE STIMULATION; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN SECRETION; RAT; SENSORY NERVE; SKIN NERVE; TAIL; ANIMAL; ANIMAL BEHAVIOR; ANIMAL DISEASE; CELL COUNT; CHEMICALLY INDUCED DISORDER; COMPARATIVE STUDY; DRUG ADMINISTRATION ROUTE; DRUG ANTAGONISM; DRUG INTERACTION; ELECTRON MICROSCOPY; IMMUNOLOGY; INSTRUMENTATION; METABOLISM; METHODOLOGY; PAIN; PAIN ASSESSMENT; PATHOPHYSIOLOGY; PHYSIOLOGY; SPRAGUE DAWLEY RAT; STIMULATION; TIME; ULTRASTRUCTURE;

ANALGESIA; ANIMALS; BEHAVIOR, ANIMAL; CAPSAICIN; CELL COUNT; DRUG ADMINISTRATION ROUTES; DRUG INTERACTIONS; FORMALDEHYDE; FREUND'S ADJUVANT; MALE; MICROSCOPY, ELECTRON; PAIN; PAIN MEASUREMENT; PEPTIDES; PEPTIDES, CYCLIC; PERIPHERAL NERVES; PHYSICAL STIMULATION; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, SOMATOSTATIN; TIME FACTORS;

EID: 0141957908     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0306-4522(03)00337-3     Document Type: Article

References (33)

1. Bourke D.L. Counter-irritation reduces pain during cutaneous needle insertion. Anesth Analg. 64:1985;377-382.
2. Carlton S.M., Du J., Davidson E., Zhou S., Coggeshall R.E. Somatostatin receptors on peripheral primary afferent terminals inhibition of sensitized nociceptors . Pain. 90:2001;233-244.
3. Carlton S.M., Du J., Zhou S., Coggeshall R.E. Tonic control of peripheral cutaneous nociceptors by somatostatin receptors. J Neurosci. 21:2001;4042-4049.
4. Coggeshall R.E., Carlton S.M. Ultrastructural analysis of NMDA, AMPA and kainate receptors on unmyelinated and myelinated axons in the periphery. J Comp Neurol. 391:1998;78-86.
5. Danziger N., Gautron M., Le Bars D., Bouhassira D. Activation of diffuse noxious inhibitory controls (DNIC) in rats with an experimental peripheral mononeuropathy. Pain. 91:2001;287-296.
6. Dubuisson D., Dennis S.G. The formalin test a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats . Pain. 4:1977;161-174.
7. Fields H.L., Basbaum A. Central nervous system mechanisms of pain modulation. Wall P.D., Melzack R. Textbook of pain. 1994;243-260 Churchill Livingstone, London.
8. Gammon G.D., Starr I. Studies on the relief of pain by counter-irritation. J Clin Invest. 20:1941;13-20.
9. Gross D. Multifactorial diagnosis and therapy for low back pain. Bonica J.J. Advances in pain research and therapy. 1979;671-683 Raven Press, New York.
10. Guieu R., Serratrice G., Pouget J. Counter-irritation test in primary fibromyalgia. Clin Rheumatol. 13:1994;605-610.
11. Hardy J.D., Wolff H.G., Goodell H. Studies on pain a new method for measuring pain threshold: observations on spatial summation of pain . J Clin Invest. 19:1940;649-657.
12. Heapy C.G., Jamieson A., Russell N.J.W. Afferent C-fibre and Aδ activity in models of inflammation. Br J Pharmacol. 90:1987;164P.
13. Helyes Z., Than M., Oroszi G., Pinter E., Nemeth J., Keri G., Szolcsányi J. Anti-nociceptive effect induced by somatostatin released from sensory nerve terminals and by synthetic somatostatin analogues in the rat. Neurosci Lett. 278:2000;185-188.
14. Heppelmann B., Pawlak M. Inhibitory effect of somatostatin on the mechanosensitivity of articular afferents in normal and inflamed knee joints of the rat. Pain. 73:1997;377-382.
15. Hökfelt T., Elde R., Hohansson O., Luft R., Arimura A. Immunohistochemical evidence for the presence of somatostatin, a powerful inhibitory peptide, in some primary sensory neurons. Neurosci Lett. 1:1975;231-235.
16. Kakigi R., Watanabe S. Pain relief by various kinds of interference stimulation applied the peripheral skin in humans pain-related brain potential following CO2 laser stimulation . Peripher Nerv Sys. 1:1996;189-198.
17. Le Bars, D, Calvino, B, Villanueva, L, Cadden, SW (1984) Physiological approaches to counter-irritation phenomena. In: Stress-induced analgesia (Tricklebank MD, Curzon G, eds), pp 67-101. New York: John Wiley & Sons.
18. Le Bars D., Dickenson A.H., Besson J.-M. Diffuse noxious inhibitory controls (DNIC) I . Effects on dorsal horn convergent neurones in the rat. Pain. 6:1979;283-304.
19. Le Bars D., Dickenson A.H., Besson J.-M. Diffuse noxious inhibitory controls (DNIC) II . Lack of effect on non-convergent neurones, supraspinal involvement and theoretical implications. Pain. 6:1979;305-327.
20. Lin Q., Wu J., Willis W.D. Dorsal root reflexes and cutaneous neurogenic inflammation after intradermal injection of capsaicin in rats. J Neurophysiol. 82:1999;2602-2611.
21. Lin Q., Zou X., Willis W.D. Aδ and C primary afferents convey dorsal root reflexes after intradermal injection of capsaicin in rats. J Neurophysiol. 84:2000;2695-2698.
22. Melzack R. Prolonged relief of pain by brief, intense transcutaneous somatic stimulation. Pain. 1:1975;357-373.
23. Melzack R. Folk medicine and the sensory modulation of pain. Wall P.D., Melzack R. Textbook of pain. 1995;1209-1217 Churchill Livingstone, New York.
24. Morgan M.M., Whitney P.K. Behavioral analysis of diffuse noxious inhibitory controls (DNIC) antinociception and escape reactions . Pain. 66:1996;307-312.
25. Pugsley T.A., Lippmann W. Effect of somatostatin analogues and 17-α-dihydroequilin on rat brain opiate receptors. Res Comm Chem Path Pharm. 21:1978;153-157.
26. Puig S., Sorkin L.S. Formalin-evoked activity in identified primary afferent fibers systemic lidocaine suppresses phase-2 activity . Pain. 64:1996;345-355.
27. Rezek M., Havlicek V., Leybin L., LaBella F.S., Friesen H. Opiate-like naloxone-reversible action of somatostatin given intracerebrally. Can J Phys Pharm. 56:1978;227-231.
28. Roby-Brami A., Bussel B., Willer J.C., LeBars D. An electrophysiological investigation into the pain-relieving effects of heterotopic nociceptive stimuli probable involvement of a supraspinal loop . Brain. 110:1987;1497-1508.
29. Szolcsányi J., Helyes Z., Oroszi G., Nemeth J., Pintér E. Release of somatostatin and its role in the mediation of the anti-inflammatory effect induced by antidromic stimulation of sensory fibres of rat sciatic nerve. Br J Pharmacol. 123:1998;936-942.
30. Szolcsányi J., Pintér E., Helyes Z., Oroszi G., Nemeth J. Systemic anti-inflammatory effect induced by counter-irritation through a local release of somatostatin from nociceptors. Br J Pharmacol. 125:1998;916-922.
31. Than M., Nemeth J., Szilvassy Z., Pinter E., Helyes Z., Szolcsányi J. Systemic anti-inflammatory effect of somatostatin released from capsaicin-sensitive vagal and sciatic sensory fibres of the rat and guinea-pig. Eur J Pharm. 399:2000;251-258.
32. Willis W.D. Dorsal root potentials and dorsal root reflexes a double-edged sword . Exp Brain Res. 124:1999;395-421.
33. Zimmermann M. Ethical guidelines for investigations of experimental pain in conscious animals. Pain. 16:1983;109-110.